Testosterone Replacement Therapy for Testosterone Deficiency in Older Men.

Testosterone therapy demonstrated benefits in sexual function among older men with testosterone deficiency.

• Evidence drawn from the Testosterone Trials (TTrials) and the TRAVERSE trial (Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men)
• Sexual function was identified as one of the primary domains showing improvement with testosterone replacement therapy
• Benefits were observed in the context of age-related symptoms including decreased libido

Testosterone therapy was associated with improvements in physical performance in aging men.

• Physical performance improvements were documented alongside sexual function and bone density benefits
• Age-related symptoms addressed included muscle weakness, which is a target outcome for testosterone replacement
• Findings were supported by major clinical trials including the Testosterone Trials

Testosterone therapy improved bone density in older men with testosterone deficiency.

• Bone density was identified as one of three primary benefit domains alongside sexual function and physical performance
• Results were supported by evidence from both the Testosterone Trials and the TRAVERSE trial
• Bone density improvements are clinically relevant given the aging population's susceptibility to osteoporosis

Testosterone therapy showed no significant increase in risk for cardiovascular events in older men.

• The TRAVERSE trial (Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men) was specifically designed to assess long-term vascular events
• No significant increase in cardiovascular event risk was identified across the reviewed studies
• This finding was noted despite the review population being older men, who may have existing health conditions

Testosterone therapy was not associated with a significant increase in prostate cancer risk.

• No significant increase in prostate cancer risk was found in studies including the Testosterone Trials and TRAVERSE trial
• This addresses a historically cited concern about androgen-driven prostate cancer promotion
• The finding supports the safety profile of testosterone therapy with respect to prostate malignancy

Conflicting data in the literature necessitate careful, individualized treatment approaches for testosterone therapy in older men.

• The review identified conflicting data across studies regarding the overall risk-benefit profile of testosterone therapy
• Individualized treatment was deemed especially necessary for older men with existing health conditions
• The review highlights that the increasing use of testosterone therapy must be balanced against patient-specific factors

Testosterone therapy use in aging men is increasing, driven by the need to address age-related symptoms.

• Age-related symptoms prompting therapy include decreased libido, muscle weakness, and anemia
• The review characterizes the trend as an 'increasing use of testosterone therapy in aging men'
• Anemia is listed among the target symptoms, alongside more commonly cited sexual and physical symptoms